U.S. government suspends enrollment in Cigna Medicare Advantage drug plans

Posted Jan. 28, 2016

By Caroline Humer (edited)

 

(Reuters) - The U.S. government has suspended new enrollment in Cigna Corp's Medicare Advantage health insurance and prescription drug plans, saying Cigna had "widespread and systemic failures" that prevented patients from accessing medical services. The government said Cigna did not handle complaints and grievances properly from patients who had been denied coverage for health benefits or drugs, according to a Jan. 21 letter from its regulator, the Centers for Medicare and Medicaid.

 

Officials also found problems with its list of covered drugs and said it did not handle its requests for prior authorization and exceptions as it should have.

 

Cigna said in a regulatory filing the suspension, effective immediately, does not affect members currently enrolled in the plans.

 

Sanctions will remain in place until Cigna makes changes and the problems are deemed unlikely to recur, according to the letter. Cigna is due to submit a corrective plan by Jan. 29.